Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HR18034 for postoperative analgesia in hemorrhoidectomy
NCT05769855Phase 3Completed
- Sponsor
- Hengrui Therapeutics
- Start
- Mar 2023
- Primary completion
- Oct 2023
- Modality
- Small Molecules, Lipid-based Nanoparticles
- Countries
- 1
01
Overview
A Phase 3 trial of bupivacaine liposome in postoperative pain, sponsored by Hengrui Therapeutics. Started Mar 2023; status: completed.
02
Drugs
bupivacaine liposome
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT05769855.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05769855.